Literature DB >> 8046349

Recognition of carbohydrate by major histocompatibility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes.

J S Haurum1, G Arsequell, A C Lellouch, S Y Wong, R A Dwek, A J McMichael, T Elliott.   

Abstract

Cytotoxic T cells (CTL) recognize short peptide epitopes presented by class I glycoproteins encoded by the major histocompatibility complex (MHC). It is not yet known whether peptides containing posttranslationally modified amino acids can also be recognized by CTL. To address this issue, we have studied the immunogenicity and recognition of a glycopeptide carrying an O-linked N-acetylglucosamine (GlcNAc) monosaccharide-substituted serine residue. This posttranslational modification is catalyzed by a recently described cytosolic glycosyltransferase. We show that glycosylation does not affect peptide binding to MHC class I and that glycopeptides can elicit a strong CTL response that is glycopeptide specific. Furthermore, glycopeptide recognition by cytotoxic T cells is dependent on the chemical structure of the glycan as well as its position within the peptide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046349      PMCID: PMC2191607          DOI: 10.1084/jem.180.2.739

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  24 in total

1.  Peptide selection by class I molecules of the major histocompatibility complex.

Authors:  T Elliott; M Smith; P Driscoll; A McMichael
Journal:  Curr Biol       Date:  1993-12-01       Impact factor: 10.834

2.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

Authors:  R E Phillips; S Rowland-Jones; D F Nixon; F M Gotch; J P Edwards; A O Ogunlesi; J G Elvin; J A Rothbard; C R Bangham; C R Rizza
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

3.  Empty MHC class I molecules come out in the cold.

Authors:  H G Ljunggren; N J Stam; C Ohlén; J J Neefjes; P Höglund; M T Heemels; J Bastin; T N Schumacher; A Townsend; K Kärre
Journal:  Nature       Date:  1990-08-02       Impact factor: 49.962

4.  The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc.

Authors:  G D Holt; G W Hart
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

5.  Localization of allodeterminants on H-2Kb antigens determined with monoclonal antibodies and H-2 mutant mice.

Authors:  G J Hämmerling; E Rüsch; N Tada; S Kimura; U Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  Peptide-conjugated hapten groups are the major antigenic determinants for trinitrophenyl-specific cytotoxic T cells.

Authors:  A von Bonin; B Ortmann; S Martin; H U Weltzien
Journal:  Int Immunol       Date:  1992-08       Impact factor: 4.823

7.  O-linked GlcNAc in serotype-2 adenovirus fibre.

Authors:  M L Caillet-Boudin; G Strecker; J C Michalski
Journal:  Eur J Biochem       Date:  1989-09-01

8.  Localization of O-GlcNAc modification on the serum response transcription factor.

Authors:  A J Reason; H R Morris; M Panico; R Marais; R H Treisman; R S Haltiwanger; G W Hart; W G Kelly; A Dell
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

9.  Virion basic phosphoprotein from human cytomegalovirus contains O-linked N-acetylglucosamine.

Authors:  D M Benko; R S Haltiwanger; G W Hart; W Gibson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

10.  Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid.

Authors:  R D Salter; P Cresswell
Journal:  EMBO J       Date:  1986-05       Impact factor: 11.598

View more
  41 in total

1.  Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo.

Authors:  J S Haurum; I B Høier; G Arsequell; A Neisig; G Valencia; J Zeuthen; J Neefjes; T Elliott
Journal:  J Exp Med       Date:  1999-07-05       Impact factor: 14.307

2.  A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor.

Authors:  Vasso Apostolopoulos; Elizabeth Yuriev; Paul A Ramsland; Jodie Halton; Carla Osinski; Wenjun Li; Magdalena Plebanski; Hans Paulsen; Ian F C McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

3.  Processing of glycans on glycoprotein and glycopeptide antigens in antigen-presenting cells.

Authors:  Ole Werdelin; Morten Meldal; Teis Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-16       Impact factor: 11.205

Review 4.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

5.  O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.

Authors:  D Stepensky; E Tzehoval; E Vadai; L Eisenbach
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

6.  Identification of Glycopeptides as Posttranslationally Modified Neoantigens in Leukemia.

Authors:  Stacy A Malaker; Sarah A Penny; Lora G Steadman; Paisley T Myers; Justin C Loke; Manoj Raghavan; Dina L Bai; Jeffrey Shabanowitz; Donald F Hunt; Mark Cobbold
Journal:  Cancer Immunol Res       Date:  2017-03-17       Impact factor: 11.151

7.  A post-translational modification of nuclear proteins, N(G),N(G)-dimethyl-Arg, found in a natural HLA class I peptide ligand.

Authors:  J Yagüe; J Vázquez; J A López de Castro
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

8.  Rheumatoid arthritis: autoreactive T cells recognising a novel 68k autoantigen.

Authors:  S Bläss; C Haferkamp; C Specker; M Schwochau; M Schneider; E M Schneider
Journal:  Ann Rheum Dis       Date:  1997-05       Impact factor: 19.103

9.  Immunogenicity of bacterial carbohydrates: cholera toxin modulates the immune response against dextran B512.

Authors:  E Sverremark; C Fernandez
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

Review 10.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.